D. Adkins
Papers
1
Total Citations
5
H-Index
1
About
Dr. D. Adkins is a leading oncologist whose research focuses on human papillomavirus-positive oropharyngeal squamous-cell carcinoma (HPV+ OPSCC), particularly in developing risk-directed, de-escalated treatment strategies to reduce long-term toxicity without compromising survival. Their most impactful work, a non-randomized, multi-arm Phase 2 trial published in 2024, demonstrated the long-term efficacy of de-escalated adjuvant therapy for surgically resected locally advanced HPV+ OPSCC, showing that patients can achieve excellent outcomes with less intensive regimens. This study, which has already garnered 5 citations, challenges traditional aggressive treatment paradigms and offers a personalized approach based on individual risk profiles. Dr. Adkins’ contributions are pivotal in shifting clinical practice toward minimizing the debilitating side effects of chemoradiation, such as dysphagia and xerostomia, while maintaining high cure rates. Their work is widely recognized for its potential to improve quality of life for thousands of patients annually, and they continue to lead trials that refine risk stratification and optimize therapeutic de-escalation in head and neck cancers.
Research Focus
Key Achievements
Top Papers
- 1